FDA approves Abraxane for late-stage pancreatic cancer
Friday, September 6, 2013 - 15:00
in Health & Medicine
The U.S. Food and Drug Administration today expanded the approved uses of Abraxane (paclitaxel protein-bound particles for injectable suspension, albumin-bound) to treat patients with late-stage...